Atherogeneis is a chronic progressive syndrome caused by endothelial dysfunction, vascular inflammation, vessel wall remodeling and eventual vascular flow compromise. Emerging data suggest that arterial compliance inversely correlates with atherogenesis and cardiovascular (CV) events. However, information is scant on the association of chronic systemic inflammation with arterial elasticity in young asymptomatic adults. The association of hsC-reactive protein (CRP) and central-vascular compliance was studied in 641 individuals (45.2% males; 71.8% whites), aged 31-43 years enrolled in the Bogalusa Heart Study. The measured variables included large-artery compliance (capacitive, C1), representative of the aorta and its major branches; and small-artery compliance (oscillatory, C2), representative of the distal part of the circulation; hsCRP, as a measure of systemic inflammation; along with traditional CV risk factor variables. Significant race and sex differences were noted for C1 (white males4black males P-value o0.0001; males4females P-value 0.04), C2 (whites4blacks P-value 0.0004; males4females P-valueo0.0001) and hsCRP (blacks4whites P-value 0.03; females4males P-value 0.002). Mean values of C1 in subjects with high hsCRP levels (43 mg l À 1 ) were significantly lower than those with average (1-3 mg l À 1 ) and low levels (o1 mg l À 1 ) (14.2 ml per mmHg Â 10 versus 15.2 ml per mm Hg Â 10 versus 15.7 ml per mmHg Â 10, P for trend ¼ 0.02), after adjusting for age, race, sex and body surface area (BSA). hsCRP showed a trend toward inverse correlation with C1 ( À 0.07, P ¼ 0.07) but no such trend for C2, after adjusting for race and sex. In the multivariate linear regression model, adding age, race, sex, BSA, mean arterial pressure, insulin resistance, lipoprotein variables and smoking status, the effect persisted between C1 and hsCRP (b ¼ À 0.35, P ¼ 0.01). In an asymptomatic population of young adults, hsCRP predicts reduced large-artery compliance (C1). These findings support the role of systemic inflammation in early pathological changes in artery wall in atherogenesis. Small-artery compliance (C2) however did not correlate with hsCRP.
INTRODUCTION
Atherogenesis is a complex syndrome. One of the earliest changes in this process is endothelial dysfunction. This is evidenced by increased levels of biochemical markers of endothelial function like vascular cell adhesion molecule 1 (VCAM-1). This results in recruitment of pro-inflammatory cells in the subendothelium and release in cytokines like IL-6. These cytokines stimulate the liver to produce other inflammatory markers like C-reactive protein (CRP), which further promotes inflammation and recruitment of inflammatory cells in the vascular subendothelium. Plasma highsensitivity CRP is a marker of systemic inflammation that is associated with increased risk of coronary heart disease. 1 hsCRP has been shown to be directly associated with the risk for cardiovascular (CV) disease in both cross-sectional and prospective studies, [2] [3] [4] [5] although the role on how is still a matter of debate. 6 Whether hsCRP is a risk factor or merely a risk marker remains controversial. Recent studies provide evidence to support that inflammation has a role in the pathogenesis of coronary heart disease and increased pulse pressure, which is an indicator of large-artery stiffness. 7, 8 Thus, if inflammation is a marker for atherosclerotic changes, the relationship should be expressed through an inflammatory process in the wall of the conduit arteries. This process exhibits cellular proliferation, collagen synthesis and thickening of vessel wall, resulting in decreased vascular compliance and eventual plaque formation.
Arterial stiffness is an important predictor of CV morbidity and mortality. 9, 10 If arterial wall inflammation leads to arterial stiffness, then vascular compliance could be a more specific marker for vascular disease than a non-specific marker of inflammation. 11, 12 The present study investigates the association of hsCRP with large-artery elasticity index (C1) and small-artery elasticity index (C2). We hypothesize that as CRP is a marker for inflammation, it should have an inverse relationship with large-artery vascular compliance independent of traditional risk factors for coronary heart disease. Small-artery compliance (C2) however has been shown to correlate more with endothelial dysfunction, 13, 14 which precedes inflammatory changes, and hence, does not necessarily correlate with hsCRP.
METHODS

Study population
The Bogalusa Heart Study is a long-term epidemiological study of the early natural history of adult heart diseases 15 as they begin in youth. The Study is conducted in the semirural biracial (65% whites, 35% African Americans) community of Bogalusa, LA. Young adults (n ¼ 700; 71.1% whites, 56.7% 1 females) aged 31-43 years were examined for vascular compliance, CRP and CV risk factor variables. Participants whose levels of hsCRP were 410 mg l À 1 (n ¼ 49) and those with incomplete information on vascular compliance (n ¼ 10) were excluded for analysis.
Tulane University Medical Center Institutional Review Board approved the study. Informed consent was obtained from all participants.
General examination
Standardized techniques and protocols were used by trained field observers as have been described in earlier studies. 16 Anthropometric and blood pressure measurements were made in replicate and the mean values were used for analysis. Body mass index (BMI) was calculated as weight in kilograms divided by the square of height in meters and used as a measure of overall adiposity. Body surface area (BSA) was calculated as square root of weight in kilograms multiplied by height in centimeters divided by 3600. Information on smoking status was obtained by selfreported questionnaires. Those who smoked at least one cigarette per week during the past 1 year or more were identified as current smokers, the remainder, as nonsmokers.
Laboratory analysis
Subjects were instructed to fast for 12 h before screening, and the compliance was determined by interview on the morning of examination. Serum total cholesterol and triglycerides (TG) were assayed using an enzymatic procedure on the Hitachi 902 Automatic Analyzer (Roche Diagnostics, Indianapolis, IN, USA). Serum lipoprotein cholesterols including high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) were analyzed using a combination of heparin-calcium precipitation and agar-agarose gel electrophoresis procedures. 17 The laboratory has been monitored for precision and accuracy of lipid measurements by the surveillance program of the Centers for Disease Control and Prevention (Atlanta, GA, USA). Serum glucose levels were determined by a glucose oxidase method as part of SMA20. A commercial radioimmunoassay kit was used for measuring plasma immunoreactive insulin levels (Pharmacia Diagnostics, Piscataway, NJ, USA). An index of insulin resistance (homeostasis model assessment of insulin resistance (HOMA-IR)) was calculated according to the homeostasis model assessment formula: fasting insulin (in micro units per milliliter) Â fasting glucose (in mg dl À 1 )Ä405. hsCRP was measured by latex particle-enhanced immunoturbidimetric assay on Hitachi 902 Automatic Analyzer.
Arterial compliance measurements
Radial arterial pulse pressure waveforms were recorded by an acoustic transducer using the HDI/Pulse Wave CR-2000 Research Cardiovascular Profiling System (Hypertension Diagnostics, Eagan, MN, USA). A wrist stabilizer was used to gently immobilize the right wrist and stabilize the radial artery during measurements. For each subject in the supine position, pressure waveforms were recorded for 30 s, digitized at 200 samples per second, and stored in a computer. A modified Windkessel model of the circulation was used to match the diastolic pressure decay of the waveforms and to quantify changes in arterial waveform morphology in terms of large-artery (capacitive) compliance, representative of the aorta and major branches, and small-artery (oscillatory) compliance, representative of the distal part of the circulation including the arteriolar bed. 18, 19 Four measurements were taken for each subject: two repeated measurements followed by separation of sensor from the tonometer for a 5 min rest of subjects and then an additional two repeated measurements. The mean values of four values were used for analysis. The reproducibility of the measurements was validated and described in earlier studies. [20] [21] [22] [23] [24] The reproducibility in terms of intra-class correlation coefficients between first two and second two set of measurements on 800 subjects was 0.74 for large-artery compliance, 0.87 for small-artery compliance. To examine the reproducibility further, 61 randomly selected subjects were examined 1-3 h later, after the first set of observations. The intra-class correlation coefficient between these two examinations was 0.65 for large-artery compliance, 0.78 for small-artery compliance. The reproducibility of the measured variables was comparable to previous studies. In addition, systolic, diastolic and mean arterial blood pressure levels were obtained from the HDI instrument. Forced values of 140/90 mm of Hg were assigned to subjects with diagnosed hypertension on medication(s) but with normal blood pressure at screening.
Statistical methods
All statistical analyses were performed using SAS version 9.1 (SAS Institute, Cary, NC, USA). Continuous variables were tested for normality using Kolmogorov-Smirnov test. The values of TG/HDL-C ratio, HOMA-IR and CRP were log-transformed to improve the normality of distribution and analyses were performed on transformed data where appropriate. General linear models were used to examine race and sex differences in normally distributed risk factor variables after adjusting for age. Wilcoxon rank-sum test was used to examine race-sex difference for variables that were not normally distributed. Partial Pearson correlation was used for the relationship of arterial compliance with CV risk factor variables and BSA. All P-values were two-tailed and adjusted for covariates where appropriate.
Stepwise multivariate linear regression analysis was used to determine the independent association of hsCRP in relation to CV risk factor variables and arterial compliance. Model selection was based on values of correlation coefficients (Po0.1). Mean arterial pressure (MAP), TG/HDL-C, HOMA-IR were selected as indicators of hemodynamic and metabolic status. As BMI correlated highly with small-artery compliance but not largeartery compliance, two separate models without (Model I) and with (Model II) BMI were used. To examine large-arterial compliance by CRP status based on the American Heart Association/Center of Disease Control risk assessment guidelines, subjects (n ¼ 244) who had hsCRP levels below 1 mg l À 1 were categorized as low group; those (n ¼ 218) with hsCRP levels between 1 and 3 mg l
, as the average group; and those (n ¼ 179) with CRP above 3 mg l À 1 as the high group. 25 Least square means of largearterial compliance adjusted for age, race, sex and BSA were used for comparison.
RESULTS
Characteristics of the study cohort by race and sex are presented in Table 1 . With the exception of age, significant race and/or sex differences were observed for all risk factor variables listed. Blacks versus whites had higher BMI (females only), systolic blood pressure, diastolic blood pressure, MAP, HDL-C, and lower TGs, LDL-C (females only) and TG/HDL ratio. Males versus females had higher BMI (whites only), BSA, systolic blood pressure, diastolic blood pressure, MAP, TGs, LDL-C, TG/HDL ratio, glucose (whites only), insulin (whites only), HOMA-IR (whites only) and lower HDL-C (whites only). Blacks versus whites had higher prevalence of smoking (males only). Table 2 shows race and sex characteristics of the three main study variables of interest. Blacks versus whites had higher hsCRP and lower large-(males only) and small-artery compliance. Males versus females had higher compliance both for large-and small-artery compliance and lower hsCRP.
The partial Pearson correlation coefficients (adjusted for race and sex) between large-and small-artery compliance and risk factor variables are given in Table 3 . For large-artery compliance, significant inverse correlation existed for age, systolic, diastolic and mean arterial blood pressures, TG/HDL ratio, LDL-C and HOMA-IR; significant positive correlation existed for BSA. Strong relations were noted for blood pressure for both large-and smallartery compliance. HsCRP, showed a trend towards significant correlation with large-artery compliance (Po0.1). For small-artery compliance, significant inverse correlation existed for age, and systolic, diastolic and mean arterial blood pressures; significant positive correlations existed for BMI and BSA. Figure 1 shows mean values of large-artery compliance in subjects by hsCRP levels (low: o1 mg l À 1 , average: 1-3 mg l
and high:43 mg l À 1 ). Large-artery compliance was significantly higher in low and average groups as compared with the high hsCRP group. Table 4 
DISCUSSION
In our cohort, black males had a lower central-vascular compliance than white males (Table 2) . Smoking is an independent CV risk factor and has shown inverse correlation with central-vascular compliance. There was a higher incidence of smoking among black males compared with white males (44 versus 29% P-value 0.02). Whether this difference in the incidence of smoking can account for the observed difference in central-vascular C-reactive protein and arterial compliance D Sharma et al compliance is unknown. Further studies need to be done to evaluate this observation. The correlation of hsCRP levels and the risk of CV morbid events are indicative of the role of inflammation either as a marker or a contributor to atherosclerotic vascular disease. [26] [27] [28] [29] [30] The physiological parameter that links inflammation in the vessel wall and progression of arterial wall structural changes may be a decrease in vascular compliance and vascular stiffness. This inflammatory process is reflected by the association of hsCRP levels with vascular compliance of large (C1) arteries in our study.
The large-artery compliance and subsequent progression of the atherosclerotic process are dependent for their development on endothelial dysfunction, which permits expression of adhesion molecules, infiltration and subsequent inflammatory structural changes. This onset of inflammation is characterized by recruitment release of inflammatory markers and cytokines. These adverse group of changes further facilitates the infiltrative process via release of pro-inflammatory markers like hsCRP. This infiltration and inflammation results in vascular wall structural changes 13, 14 in the form of stiffening and progressive decreasing compliance. Thus over time as noted by age effect in those studies, it seems that endothelial dysfunction and subsequent inflammation are determinants to the progression of atherogenesis of the vascular wall.
There is considerable evidence that small-artery compliance correlates with markers of endothelial dysfunction. 31, 32 Reduced nitric oxide (NO) bioactivity is a known marker of endothelial dysfunction and also a precursor of atherosclerosis. In vivo infusion of substituted arginine NG-nitro-L-arginine-methyl ester (L-NAME), which is a potent inhibitor of NO release, has been related to decreased small-artery compliance (C2). 32 Hence, it seems reasonable to hypothesize the hsCRP, large-vessel compliance (C1) and endothelial dysfunction (C2) should have modest correlation with risk factors for coronary heart disease. Our study supports that construct.
The process of atherogenesis is complex. In addition to the inverse correlation of hsCRP and central-vascular compliance indices, there are multiple factors that influence atherogenesis. The earliest change in the plaque development process is the upregulation of adhesion molecules in the vascular endothelium. This allows penetration of leukocytes in the subendothelial layer and release of tumor necrosis factor a, interleukin (IL-6) and other cytokines. This process starts a cascade of intimal changes involving further recruitment of leukocytes and other pro-inflammatory agents. HsCRP further potentiates inflammation and complement activation in the vascular wall. Thus, hsCRP that is released by the liver in response to IL-6 acts both as a marker and promoter of atherogenesis. Generation of reactive oxygen molecules is a key determinant of the inflammatory response in the vessels. 33 Aging promotes decreased vascular compliance, which is consistent with a positive correlation of age and coronary artery disease. However, hsCRP does not increase with age and may not correlate with small-artery compliance as a marker of small-artery compliance. It seems that hsCRP might accelerate rather than initiate the atherosclerotic process in individuals who exhibit early disease.
The role of hsCRP and its effect on central-vascular compliance might be helpful in guiding primary prevention of coronary artery disease. Studies have shown that the severity of coronary artery disease is related more to central pressures and compliance than brachial pressures. 34 The most significant study to demonstrate the significance of central pressures over brachial pressure is the Conduit Artery Function Evaluation (CAFÉ) study of the AngloScandinavian Cardiac Outcomes Trial (ASCOT) hypertension trial. 35 This study showed that although the brachial pressure was reduced to a similar extent by both the atenolol ± thiazide and amlodipine ± perinopril arms, central pressures and pulse pressures were significantly lower in the amlodipine-based treatments. It is however uncertain whether lower post hoc events in the amlodipine arm were related to lower central pressures. However, as hsCRP correlates to central-vascular compliance, which in turn is a major contributor of central pressures, this observation may have some implications in initiating certain class of anti-hypertensive agents. Further longitudinal studies are needed to investigate these associations.
As a limitation, this study is observational and cross-sectional in nature and therefore cannot establish causality, it does support potential mechanisms as mentioned above. Confounding factors or reverse causality offer alternative explanations for the association of hsCRP and atherogenesis. The levels of hsCRP can be influenced by a variety of inflammatory conditions. Every effort was made to exclude subjects with very high hsCRP levels (410 mg l À 1 ); however, whether this exclusion completely eliminates the interference of non-vascular inflammatory conditions is unclear. Smoking history in patients is taken as a yes/no answer instead of a quantitative estimate based on pack years of smoking. CONCLUSION hsCRP, a marker of systemic inflammation, is associated with large-artery compliance and possibly small-artery changes in young asymptomatic individuals. These observations support the growing evidence of inflammation in early process of hypertensive atherogenesis and concomitant structural changes in vessel walls. The findings have implications for preventive cardiology.
What is known about this topic
Atherosclerosis is a complex process. This process includes endothelial dysfunction followed by vascular inflammation and eventual vessel wall remodeling. Central-vascular pressures correlate better than brachial blood pressures in predicting CV events. Central-vascular pressures are primarily determined by centralvascular compliance.
What this study adds
This study attempts to support the role of systemic inflammation in early pathogenesis of atherosclerosis. The study attempts to evaluate the relationship of marker of systemic inflammation (hsCRP) with central-vascular compliance. This study might stimulate further interest in incorporating measurements of hsCRP in preventive cardiology to target high-risk population. 
